Prevalence of anemia and effects on mortality in patients with heart failure.

[1]  J. McMurray,et al.  Anemia and Its Relationship to Clinical Outcome in Heart Failure , 2004, Circulation.

[2]  D. Schwartz,et al.  Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. , 2004, International journal of cardiology.

[3]  P. Poole‐Wilson,et al.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial , 2004 .

[4]  B. Massie,et al.  Chronic heart failure is not an independent cause of anemia , 2003 .

[5]  C. O'connor,et al.  Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.

[6]  P. Ponikowski,et al.  Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. , 2003, International journal of cardiology.

[7]  P. Poole‐Wilson,et al.  Haemoglobin concentration and prognosis in new cases of heart failure , 2003, The Lancet.

[8]  D. Mozaffarian,et al.  Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). , 2003, Journal of the American College of Cardiology.

[9]  E. Havranek,et al.  Age, but not sex, influences the measurement of ejection fraction in elderly patients hospitalized for heart failure. , 2003, Journal of cardiac failure.

[10]  P. Ponikowski,et al.  Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.

[11]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[12]  James B. Young,et al.  Anemia in ambulatory patients with chronic heart failure: A single-center clinical experience derived from electronic medical records , 2003 .

[13]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[14]  Harlan M Krumholz,et al.  The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.

[15]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[16]  L. Lund,et al.  Hemodilution Is Common in Patients With Advanced Heart Failure , 2003, Circulation.

[17]  O. Hess,et al.  The prevalence of anemia in chronic heart failure. , 2002, International journal of cardiology.

[18]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[19]  J. Cohn,et al.  Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. , 2002, Journal of the American College of Cardiology.

[20]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[21]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[22]  A. Struthers,et al.  Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? , 2002, Heart.

[23]  S. Anker,et al.  Anaemia in chronic heart failure The relationship to inflammatory cytokine expression and prognostic importance , 2002 .

[24]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[25]  P. Mohacsi,et al.  Serum erythropoietin in heart failure patients treated with ACE‐inhibitors or AT1 antagonists , 2000, European journal of heart failure.

[26]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[27]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[28]  H. Krumholz,et al.  Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. , 1999, American heart journal.

[29]  M. Bakkaloğlu,et al.  Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  P. Wilson,et al.  Prevalence of cobalamin deficiency in the Framingham elderly population. , 1994, The American journal of clinical nutrition.

[31]  R. Riezler,et al.  Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. , 1993, The American journal of clinical nutrition.

[32]  J. Grigsby,et al.  High Prevalence of Cobalamin Deficiency in Elderly Outpatients , 1992, Journal of the American Geriatrics Society.